Simultaneous Modulated Accelerated Radiation Therapy and Concurrent Weekly Paclitaxel in the Treatment of Locally Advanced Nasopharyngeal Carcinoma

Xie, Cong-Ying; Jin, Xian-Ce; Deng, Xia; Xue, Sheng-Liu; Jing, Zhao; Su, Hua-Fang; Wu, Shi-Xiu

추천

검색

자료유형: 학술저널

저자정보: Xie, Cong-Ying (Department of Radiotherapy and Chemotherapy, the 1st Affiliated Hospital of Wenzhou Medical College) Jin, Xian-Ce (Department of Radiotherapy and Chemotherapy, the 1st Affiliated Hospital of Wenzhou Medical College) Deng, Xia (Department of Radiotherapy and Chemotherapy, the 1st Affiliated Hospital of Wenzhou Medical College) Xue, Sheng-Liu (Department of Radiotherapy and Chemotherapy, the 1st Affiliated Hospital of Wenzhou Medical College) Jing, Zhao (Department of Radiotherapy and Chemotherapy, the 1st Affiliated Hospital of Wenzhou Medical College) Su, Hua-Fang (Department of Radiotherapy and Chemotherapy, the 1st Affiliated Hospital of Wenzhou Medical College) Wu, Shi-Xiu (Department of Radiotherapy and Chemotherapy, the 1st Affiliated Hospital of Wenzhou Medical College)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제13권 제12호

발행연도: 2012.1

수록면: 6,129 - 6,132 (4page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Objectives: To evaluate the feasibility and efficacy of simultaneous accelerated radiation therapy (SMART) and concurrent weekly paclitaxel in the treatment of locally advanced nasopharyngeal carcinoma. Methods: Forty-one patients with pathologically confirmed nasopharyngeal carcinoma were treated by SMART with concurrent weekly paclitaxel. Daily fraction doses of 2.5 Gy and 2.0 Gy were prescribed to the gross tumor volume (GTV) and clinical target volume (CTV) to a total dose of 70 Gy and 56 Gy, respectively. Paclitaxel of $45mg/m^2$ was administered concurrently with radiation therapy every week. Adjuvant chemotherapy was given four weeks after the completion of the radiotherapy (RT) if the tumor demonstrated only a partial response (PR). Results: All patients completed the radiotherapy (RT) course. Adjuvant chemotherapy was administered to 12 patients due to PR. The CR (complete remission) rate was 82.9% three months after RT. Thirty-nine (95.1%) patients completed the concurrent weekly chemotherapy with paclitaxel, and two patients skipped their sixth course. Seven patients had a 15% dosage reduction at the fifth and sixth course due to grade 3 mucositis. The median follow-up was 30 (range, 14-42) months. The three-year overall survival (OS), metastases-free survival (MFS), and local control rates were 77.0%, 64.4%, and 97.6%, respectively. No correlation between survival rate and T or N stage was observed. Grade 3 acute mucositis and xerostomia were present in 17.1% and 7.1%, respectively. Conclusion: SMART with concurrent weekly paclitaxel is a potentially effective and toxicity tolerable approach in the treatment of locally advanced NPC.

#Nasopharyngeal carcinoma #SMART #concurrent chemotherapy #paclitaxel

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

이 논문의 저자 정보

Xie, Cong-Ying

소속기관 Department of Radiotherapy and Chemotherapy, the 1st Affiliated Hospital of Wenzhou Medical College